Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rosanne Poston
Institution:
Moderna Therapeutics (United States)
Observed institution:
Moderna Therapeutics (United States)
OpenAlex ID:
A5114062473
Interim safety and immunogenicity of COVID-19 omicron BA.1 variant-containing vaccine in children in the USA: an open-label non-randomised phase 3 trial
2024
·
Avika Dixit
, Richard Bennett
, et al.
·
The Lancet Infectious Diseases
·
6
PDF
Interim Safety and Immunogenicity of COVID-19 Omicron-BA.1 Variant-Containing Vaccine in Children
2023
·
Avika Dixit
, Richard Bennett
, et al.
·
medRxiv
·
3
PDF
Show more works
View as search
Works count:
2
Citation count:
9
H-index:
2
I10-index:
Year
Topic
Type
